PT2486026T - Derivados de di(fenilpropanoide)glicerol para o tratamento de cancro - Google Patents
Derivados de di(fenilpropanoide)glicerol para o tratamento de cancroInfo
- Publication number
- PT2486026T PT2486026T PT108215328T PT10821532T PT2486026T PT 2486026 T PT2486026 T PT 2486026T PT 108215328 T PT108215328 T PT 108215328T PT 10821532 T PT10821532 T PT 10821532T PT 2486026 T PT2486026 T PT 2486026T
- Authority
- PT
- Portugal
- Prior art keywords
- phenylpropanoid
- glycerol
- cancer
- derivatives
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25028709P | 2009-10-09 | 2009-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2486026T true PT2486026T (pt) | 2020-08-21 |
Family
ID=43352967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT108215328T PT2486026T (pt) | 2009-10-09 | 2010-10-08 | Derivados de di(fenilpropanoide)glicerol para o tratamento de cancro |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9061993B2 (enExample) |
| EP (1) | EP2486026B1 (enExample) |
| JP (1) | JP5529280B2 (enExample) |
| CN (1) | CN102264713A (enExample) |
| BR (1) | BR112012008204A2 (enExample) |
| CA (1) | CA2715662C (enExample) |
| CY (1) | CY1123161T1 (enExample) |
| DK (1) | DK2486026T3 (enExample) |
| ES (1) | ES2810906T3 (enExample) |
| HR (1) | HRP20201217T1 (enExample) |
| HU (1) | HUE051549T2 (enExample) |
| LT (1) | LT2486026T (enExample) |
| MX (1) | MX360417B (enExample) |
| MY (2) | MY160378A (enExample) |
| PL (1) | PL2486026T3 (enExample) |
| PT (1) | PT2486026T (enExample) |
| RS (1) | RS60667B1 (enExample) |
| SI (1) | SI2486026T1 (enExample) |
| SM (1) | SMT202000428T1 (enExample) |
| WO (1) | WO2011041907A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8907117B2 (en) * | 2011-09-08 | 2014-12-09 | Henry Lowe | Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues |
| US20160106722A1 (en) | 2014-10-21 | 2016-04-21 | Life Plus, LLC | Human therapeutic agents |
| US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
| US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
| US12129265B2 (en) | 2020-07-21 | 2024-10-29 | Ankh Life Sciences Limited | Therapeutic agents and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3857873A (en) * | 1974-02-11 | 1974-12-31 | Warner Lambert Co | 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols |
| CH648753A5 (de) * | 1981-07-22 | 1985-04-15 | Givaudan & Cie Sa | Lichtschutzmittel. |
| CN1238333C (zh) * | 2003-06-18 | 2006-01-25 | 清华大学 | 药物化合物菠萝酰酯及其制备方法和用途 |
| US7713556B2 (en) * | 2006-12-08 | 2010-05-11 | Henry Lowe | Anti-tumor and anti-inflammatory extracts of plant biomass and their uses |
| AU2008205312B2 (en) * | 2007-01-08 | 2013-11-21 | Annji Pharmaceutical Co., Ltd. | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof |
| TWI383251B (zh) * | 2008-01-16 | 2013-01-21 | Eternal Chemical Co Ltd | 感光型聚醯亞胺 |
| KR101074149B1 (ko) * | 2009-04-15 | 2011-10-17 | 한밭대학교 산학협력단 | 신규 폴리페놀/폴리페놀 컨쥬게이트 화합물 및 그의 용도 |
| US8907117B2 (en) * | 2011-09-08 | 2014-12-09 | Henry Lowe | Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues |
-
2010
- 2010-10-08 CN CN201080003781XA patent/CN102264713A/zh active Pending
- 2010-10-08 BR BR112012008204A patent/BR112012008204A2/pt not_active Application Discontinuation
- 2010-10-08 MY MYPI2012001601A patent/MY160378A/en unknown
- 2010-10-08 CA CA2715662A patent/CA2715662C/en active Active
- 2010-10-08 MY MYPI2016000361A patent/MY187188A/en unknown
- 2010-10-08 SI SI201032026T patent/SI2486026T1/sl unknown
- 2010-10-08 ES ES10821532T patent/ES2810906T3/es active Active
- 2010-10-08 DK DK10821532.8T patent/DK2486026T3/da active
- 2010-10-08 HU HUE10821532A patent/HUE051549T2/hu unknown
- 2010-10-08 PL PL10821532T patent/PL2486026T3/pl unknown
- 2010-10-08 WO PCT/CA2010/001613 patent/WO2011041907A1/en not_active Ceased
- 2010-10-08 SM SM20200428T patent/SMT202000428T1/it unknown
- 2010-10-08 PT PT108215328T patent/PT2486026T/pt unknown
- 2010-10-08 EP EP10821532.8A patent/EP2486026B1/en active Active
- 2010-10-08 MX MX2012004160A patent/MX360417B/es active IP Right Grant
- 2010-10-08 LT LTEP10821532.8T patent/LT2486026T/lt unknown
- 2010-10-08 RS RS20200931A patent/RS60667B1/sr unknown
- 2010-10-08 US US12/901,113 patent/US9061993B2/en active Active
- 2010-10-08 JP JP2012532432A patent/JP5529280B2/ja not_active Expired - Fee Related
- 2010-10-08 HR HRP20201217TT patent/HRP20201217T1/hr unknown
-
2015
- 2015-05-17 US US14/714,318 patent/US10052301B2/en active Active
-
2020
- 2020-08-05 CY CY20201100724T patent/CY1123161T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX360417B (es) | 2018-10-25 |
| CN102264713A (zh) | 2011-11-30 |
| JP5529280B2 (ja) | 2014-06-25 |
| US20110086912A1 (en) | 2011-04-14 |
| JP2013507327A (ja) | 2013-03-04 |
| RS60667B1 (sr) | 2020-09-30 |
| CA2715662C (en) | 2013-05-07 |
| US20150246014A1 (en) | 2015-09-03 |
| MX2012004160A (es) | 2012-09-07 |
| US10052301B2 (en) | 2018-08-21 |
| BR112012008204A2 (pt) | 2017-07-18 |
| HUE051549T2 (hu) | 2021-10-28 |
| EP2486026A1 (en) | 2012-08-15 |
| SI2486026T1 (sl) | 2020-10-30 |
| US9061993B2 (en) | 2015-06-23 |
| EP2486026B1 (en) | 2020-06-24 |
| SMT202000428T1 (it) | 2020-09-10 |
| MY187188A (en) | 2021-09-09 |
| CA2715662A1 (en) | 2010-12-14 |
| MY160378A (en) | 2017-03-15 |
| PL2486026T3 (pl) | 2020-11-02 |
| DK2486026T3 (da) | 2020-08-17 |
| WO2011041907A1 (en) | 2011-04-14 |
| CY1123161T1 (el) | 2021-10-29 |
| ES2810906T3 (es) | 2021-03-09 |
| LT2486026T (lt) | 2020-09-10 |
| HRP20201217T1 (hr) | 2020-12-11 |
| EP2486026A4 (en) | 2015-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2959900T3 (pl) | Związek do leczenia raka | |
| PL2482849T3 (pl) | Skojarzona immunoterapia w leczeniu nowotworu | |
| IL215772A0 (en) | Composition for the treatment of prostate cancer | |
| IL213761A0 (en) | Novel ortho-aminoamides for the treatment of cancer | |
| IL218971A0 (en) | Sulfoxide derivatives for the treatment of tumours | |
| PT2605764E (pt) | Composições para o tratamento de cancro | |
| IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
| EP2355843B8 (en) | Vaccine for the prevention of breast cancer recurrence | |
| PT2486026T (pt) | Derivados de di(fenilpropanoide)glicerol para o tratamento de cancro | |
| IL210066A0 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
| IL225520A0 (en) | History of 4-(methylaminophenoxy)pyridin-3-yl-benzamide for cancer treatment | |
| IL220134A0 (en) | Thiazole derivatives for the treatment of diseases such as cancer | |
| AP2011005893A0 (en) | Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer. | |
| AU2009900764A0 (en) | Treatment of cancer | |
| GB2470001A9 (en) | The reason of all cancer types |